GCP
ICVX

GSA Capital Partners’s Icosavax, Inc. Common Stock ICVX Stock Holding History

GSA Capital Partners’s Portfolio ICVX Stock Details ICVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-25,618
Closed -$199K – 2030
2023
Q3 		$199K Buy
+25,618
New +$212K 0.02% 1288
2023
Q1 		– Sell
-51,509
Closed -$409K – 2029
2022
Q4 		$409K Buy
51,509
+22,643
+78% +$97.2K 0.05% 726
2022
Q3 		$91K Buy
+28,866
New +$181K 0.01% 1375

Other funds holding ICVX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

GSA Capital Partners's ICVX Position: Q4 2023 in Review

GSA Capital Partners sold out of Icosavax, Inc. Common Stock (ICVX) in Q4 2023, closing a stake of 25,618 shares — an estimated $199K sold.

GSA Capital Partners first reported a position in ICVX in Q3 2022 and held it in 3 quarters. The position peaked at $409K in Q4 2022. 93 funds tracked by Wall St. Rank hold ICVX as of Q4 2023.

  • GSA Capital Partners reported no remaining Icosavax, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • GSA Capital Partners sold 25,618 Icosavax, Inc. Common Stock shares in Q4 2023, an estimated $199K.
  • GSA Capital Partners first reported a position in Icosavax, Inc. Common Stock in Q3 2022 and held it in 3 quarters.
  • GSA Capital Partners's Icosavax, Inc. Common Stock position peaked at $409K in Q4 2022.
  • 93 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q4 2023.

Based on GSA Capital Partners's 13F filing for Q4 2023, filed 16 Feb 2024.